Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle T Long

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
JCI Insight|May 5, 2017
Metabolite profiling identifies anandamide as a biomarker of nonalcoholic steatohepatitisW Taylor Kimberly, John F O'Sullivan, Anjali K Nath, et al.
JAMA Cardiology|October 5, 2017
Association of Multiorgan Computed Tomographic Phenomap With Adverse Cardiovascular Health Outcomes: The Framingham Heart StudyRavi V Shah, Ashish S Yeri, Venkatesh L Murthy, et al.
BMC Pulmonary Medicine|May 24, 2026
CT-adipose measures identify severe SARS-CoV-2 risk beyond traditional obesity metrics: a C4R cohort studyNadine Al-Naamani, Pallavi Balte, Michael G S Shashaty, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 14, 2024
Hepatic Steatosis and Fibrosis, Cardiorespiratory Fitness, and Metabolic Mediators in the CommunityVictor V Florea, Priya Gajjar, Shi Huang, et al.
Nature Medicine|April 2, 2026
Semaglutide on liver fibrosis and heart outcomes in patients at high risk of liver fibrosis: a prespecified analysis of the SELECT randomized trialSebastian M Meyhöfer, Bertrand Cariou, Cintia Cercato, et al.
JHEP Reports : Innovation in Hepatology|February 9, 2026
Cumulative lipid exposure in young adulthood and risk of midlife MASLDYun Chen, Yinan Zheng, Longgang Zhao, et al.
Hepatology (Baltimore, Md.)|June 18, 2016
Shared genetic effects between hepatic steatosis and fibrosis: A prospective twin studyJeffrey Cui, Chi-Hua Chen, Min-Tzu Lo, et al.
The American Journal of Cardiology|September 27, 2016
Metabolomic Profiling in Relation to New-Onset Atrial Fibrillation (from the Framingham Heart Study)Darae Ko, Eric M Riles, Ernaldo G Marcos, et al.
The Journal of Clinical Investigation|October 31, 2017
Dimethylguanidino valeric acid is a marker of liver fat and predicts diabetesJohn F O'Sullivan, Jordan E Morningstar, Qiong Yang, et al.
Hepatology Communications|March 30, 2023
American College of Sports Medicine (ACSM) International Multidisciplinary Roundtable report on physical activity and nonalcoholic fatty liver diseaseJonathan G Stine, Michelle T Long, Kathleen E Corey, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
JCI Insight|May 5, 2017
Metabolite profiling identifies anandamide as a biomarker of nonalcoholic steatohepatitisW Taylor Kimberly, John F O'Sullivan, Anjali K Nath, et al.
JAMA Cardiology|October 5, 2017
Association of Multiorgan Computed Tomographic Phenomap With Adverse Cardiovascular Health Outcomes: The Framingham Heart StudyRavi V Shah, Ashish S Yeri, Venkatesh L Murthy, et al.
BMC Pulmonary Medicine|May 24, 2026
CT-adipose measures identify severe SARS-CoV-2 risk beyond traditional obesity metrics: a C4R cohort studyNadine Al-Naamani, Pallavi Balte, Michael G S Shashaty, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 14, 2024
Hepatic Steatosis and Fibrosis, Cardiorespiratory Fitness, and Metabolic Mediators in the CommunityVictor V Florea, Priya Gajjar, Shi Huang, et al.
Nature Medicine|April 2, 2026
Semaglutide on liver fibrosis and heart outcomes in patients at high risk of liver fibrosis: a prespecified analysis of the SELECT randomized trialSebastian M Meyhöfer, Bertrand Cariou, Cintia Cercato, et al.
JHEP Reports : Innovation in Hepatology|February 9, 2026
Cumulative lipid exposure in young adulthood and risk of midlife MASLDYun Chen, Yinan Zheng, Longgang Zhao, et al.
Hepatology (Baltimore, Md.)|June 18, 2016
Shared genetic effects between hepatic steatosis and fibrosis: A prospective twin studyJeffrey Cui, Chi-Hua Chen, Min-Tzu Lo, et al.
The American Journal of Cardiology|September 27, 2016
Metabolomic Profiling in Relation to New-Onset Atrial Fibrillation (from the Framingham Heart Study)Darae Ko, Eric M Riles, Ernaldo G Marcos, et al.
The Journal of Clinical Investigation|October 31, 2017
Dimethylguanidino valeric acid is a marker of liver fat and predicts diabetesJohn F O'Sullivan, Jordan E Morningstar, Qiong Yang, et al.
Hepatology Communications|March 30, 2023
American College of Sports Medicine (ACSM) International Multidisciplinary Roundtable report on physical activity and nonalcoholic fatty liver diseaseJonathan G Stine, Michelle T Long, Kathleen E Corey, et al.
Pageof 10